Share ownership Eli Lilly and Company

LLY

US5324571083

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2025-12-12 pm EST			After hours 07:43:45 pm
1,027.51 ^USD	+1.80%		1,028.95	+0.14%

Dec. 12	Health Care Flat on Defensive Bias - Health Care Roundup	DJ
Dec. 12	Sector Update: Health Care Stocks Advance Late Afternoon	MT

Share class: Eli Lilly and Company

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	949,680,694	947,847,779 ( 99.81 %)	365,000 ( 0.0384 %)	99.81 %

Major shareholders: Eli Lilly and Company

Name	Equities	%	Valuation
Lilly Endowment, Inc. 10.1 %	95,492,993	10.1 %	103 B $
Lilly Endowment, Inc. 9.754 %	92,212,610	9.754 %	99 172 M $
Vanguard Fiduciary Trust Co. 8.564 %	80,959,089	8.564 %	87 069 M $
PNC Wealth Management LLC 5.41 %	51,147,603	5.41 %	55 008 M $
BlackRock Advisors LLC 5.264 %	49,762,562	5.264 %	53 518 M $
STATE STREET CORPORATION 3.673 %	34,726,558	3.673 %	37 347 M $
Capital Research & Management Co. (Global Investors) 2.654 %	25,088,371	2.654 %	26 982 M $
Fidelity Management & Research Co. LLC 2.555 %	24,150,713	2.555 %	25 973 M $
Geode Capital Management LLC 2.096 %	19,817,887	2.096 %	21 314 M $
Eaton Vance Management 1.606 %	15,185,852	1.606 %	16 332 M $
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Caixa DTVM SA 0.00109 %	309,530	0.00109 %	11 M $
Safra Asset CTVM SA (Investment Management) 0.000147 %	41,600	0.000147 %	1 M $
Morgan Stanley Administradora de Carteiras SA 0.000067 %	18,992	0.000067 %	679 855 $
XP Allocation Asset Management Ltda. 0.000036 %	10,091	0.000036 %	361 227 $
BTG Pactual Gestão E Consultoria De Investimentos Ltda. 0.000008 %	2,290	0.000008 %	81 975 $

Breakdown by shareholder type

Institutional	80.34%
Other	6.61%
State Street Corp.	3.67%
Schweizerische Nationalbank	0.25%
Sumitomo Mitsui Trust Group, Inc.	0.21%
Manulife Financial Corp.	0.17%
Swedbank AB	0.16%
Individuals	0.15%
Governments	0.12%
Danske Bank A/S	0.07%
SEI Investments Co.	0.06%
Fifth Third Bancorp	0.05%
Skandinaviska Enskilda Banken AB	0.04%
Regions Financial Corp.	0.04%
Rathbones Group Plc	0.04%
The Bank of Nova Scotia	0.04%
Menora Mivtachim Holdings Ltd.	0.03%
ING Groep NV	0.02%
Zurich Insurance Group AG	0.02%
ABN AMRO Bank NV	0.02%
Migdal Insurance & Financial Holdings Ltd.	0.02%
Clal Insurance Enterprises Holdings Ltd.	0.01%
Cullen/Frost Bankers, Inc.	0.01%
Polar Capital Holdings Plc	0.01%
Peapack-Gladstone Financial Corp.	0.01%
Münchener Rückversicherungs-Gesellschaft AG	0.01%
Banco Bilbao Vizcaya Argentaria SA	0.01%
Associated Banc-Corp	0.01%
Unknown	7.8%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	76.6%
United Kingdom	6.91%
Canada	1.57%
Norway	1.31%
France	0.88%
Sweden	0.71%
Switzerland	0.61%
Japan	0.57%
Australia	0.5%
Germany	0.35%
Netherlands	0.34%
Denmark	0.25%
South Korea	0.24%
Hong Kong	0.23%
Luxembourg	0.17%
Individuals	0.15%
Ireland	0.12%
Belgium	0.11%
Italy	0.09%
Israel	0.07%
Liechtenstein	0.06%
Finland	0.06%
Spain	0.04%
Austria	0.04%
Cayman Islands	0.04%
New Zealand	0.04%
Brazil	0.04%
Singapore	0.03%
Czech Republic	0.02%
Slovenia	0.01%
South Africa	0.01%
United Arab Emirates	0.01%
China	0.01%
Taiwan	0.01%

Based on 1000 largest holdings

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (65.5%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.4%); - immunology diseases (9.8%); - neurology (3.3%): primarily drugs used in treating depression and schizophrenia; - other (2%). Net sales are distributed geographically as follows: the United States (67.4%), Europe (15.4%), Japan (4%), China (3.7%) and other (9.5%).

Employees

47,000

Sector

Pharmaceuticals

Calendar

Feb. 10 - Q4 2025 Earnings Release (Projected)

More about the company